Physician

Carlos A Encarnacion, M.D.

According to 2025 Medicare claims, Carlos Encarnacion, M.D. (NPI: 1245273838) practices medical oncology in the Waco, TX market, with the plurality of this provider's patient population coming from Mc Lennan, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 76712-6985. Encarnacion is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Encarnacion's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 337 traditional Medicare patients, billed 96,949 HCPCS/CPT codes, and received $1,255,280 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 702 prescription claims across 163 beneficiaries totaling $544,252 in drug costs, led by Abiraterone Acetate (Abiraterone Acetate). 2023 DME data shows 43 claims. Open Payments data shows 43 records totaling $19,944. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $875,897 and ending at $1,255,280. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $414,458 and ending at $544,252. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	401	53,938	$875,897
2016	422	66,177	$1,118,992
2017	460	102,015	$1,353,477
2018	429	79,797	$1,396,952
2019	430	118,069	$1,476,878
2020	377	101,774	$1,029,693
2021	326	77,961	$1,064,607
2022	334	93,849	$1,163,159
2023	323	78,336	$948,475
2024	337	96,949	$1,255,280

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	150	811	$414,458
2016	139	828	$717,358
2017	146	825	$579,959
2018	131	734	$338,587
2019	138	698	$377,758
2020	131	661	$399,268
2021	134	685	$397,838
2022	146	633	$434,966
2023	156	717	$411,583
2024	163	702	$544,252

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	11	$701
2016	N/R	16	$866
2017	N/R	12	$760
2018	N/R	11	$768
2019	N/R	N/R	N/R
2020	N/R	25	$2,159
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	43	$16,055
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	117	342	$94
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	181	302	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	127	271	$12
36415	Insertion of needle into vein for collection of blood sample	205	714	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	161	518	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Abiraterone Acetate	Abiraterone Acetate	25	750	$48,658
Letrozole	Letrozole	194	11,758	$2,886
Exemestane	Exemestane	33	1,386	$2,843
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	57	813	$1,900
Megestrol Acetate	Megestrol Acetate	17	528	$774

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	26	$802	Medtronic, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	17	$19,142	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Carlos A. Encarnacion, M.D.?

Tedicare shows public-source Medicare data for Carlos A. Encarnacion, M.D. (NPI 1245273838), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos A. Encarnacion, M.D. have ACO affiliation data?

Carlos A. Encarnacion, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Carlos A. Encarnacion, M.D.?

Carlos A. Encarnacion, M.D. is linked to TEXAS ONCOLOGY PA (billing NPI 1811944101) in the available physician profile data.

Does Carlos A. Encarnacion, M.D. have Open Payments data?

Carlos A. Encarnacion, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.